Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
The American Journal of Physiology
|
June 1, 1993
Transepithelial transport of cholyltaurine by Caco-2 cell monolayers is sodium dependent
C E Chandler, L M Zaccaro, J B Moberly
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 27, 1997
Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients
E A Ross, L C Koo, J B Moberly
Diabetes
|
May 1, 1989
Decreased activity of acyl-CoA:cholesterol acyltransferase by insulin in human intestinal cell line Caco-2
S Jiao, J B Moberly, T G Cole, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 12, 1999
l-2-oxothiazolidine-4-carboxylic acid modulates function of peritoneal mesothelial cells in vitro
A Breborowicz, J Wisniewska, J B Moberly, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
February 22, 2000
Decreased in vitro formation of AGEs with extraneal solution compared to dextrose-containing peritoneal dialysis solutions
D E Barre, C Chen, L Cooker, et al.
Biochimica Et Biophysica Acta
|
January 16, 1990
Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally
J B Moberly, T G Cole, D H Alpers, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 29, 2000
Maltose and isomaltose in uremic plasma following icodextrin administration
R A Burke, J B Moberly, H Patel, et al.
The American Journal of Physiology
|
August 1, 1992
Apolipoprotein expression and cellular differentiation in Caco-2 intestinal cells
R D Wagner, E S Krul, J B Moberly, et al.
Mineral and Electrolyte Metabolism
|
February 22, 2000
Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia
J B Moberly, P O Attman, O Samuelsson, et al.
Diabetes, Obesity & Metabolism
|
June 13, 2012
A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus
H S Chou, K E Truitt, J B Moberly, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
The American Journal of Physiology
|
June 1, 1993
Transepithelial transport of cholyltaurine by Caco-2 cell monolayers is sodium dependent
C E Chandler, L M Zaccaro, J B Moberly
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 27, 1997
Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients
E A Ross, L C Koo, J B Moberly
Diabetes
|
May 1, 1989
Decreased activity of acyl-CoA:cholesterol acyltransferase by insulin in human intestinal cell line Caco-2
S Jiao, J B Moberly, T G Cole, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 12, 1999
l-2-oxothiazolidine-4-carboxylic acid modulates function of peritoneal mesothelial cells in vitro
A Breborowicz, J Wisniewska, J B Moberly, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
February 22, 2000
Decreased in vitro formation of AGEs with extraneal solution compared to dextrose-containing peritoneal dialysis solutions
D E Barre, C Chen, L Cooker, et al.
Biochimica Et Biophysica Acta
|
January 16, 1990
Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally
J B Moberly, T G Cole, D H Alpers, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 29, 2000
Maltose and isomaltose in uremic plasma following icodextrin administration
R A Burke, J B Moberly, H Patel, et al.
The American Journal of Physiology
|
August 1, 1992
Apolipoprotein expression and cellular differentiation in Caco-2 intestinal cells
R D Wagner, E S Krul, J B Moberly, et al.
Mineral and Electrolyte Metabolism
|
February 22, 2000
Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia
J B Moberly, P O Attman, O Samuelsson, et al.
Diabetes, Obesity & Metabolism
|
June 13, 2012
A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus
H S Chou, K E Truitt, J B Moberly, et al.
Page
of 3